QIAGEN Partners With International Panel Physicians Association To Increase Awareness Of Tuberculosis Screening Requirements
QIAGEN Partners With International Panel Physicians Association To Increase Awareness Of Tuberculosis Screening Requirements
QIAGEN與國際專家小組醫師協會合作，提高對結核篩查要求的認識
QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA))))) today announced a partnership with the International Panel Physicians Association (IPPA) to support and educate panel physicians around the globe on the latest tuberculosis (TB) screening requirements. A special focus will be on the new Interferon Gamma Release Assay (IGRA) requirements and the associated benefits for patients and healthcare providers.
QIAGEN（紐約證券交易所代碼：QGEN，法蘭克福主要標準：QIA）））今天宣佈與國際專家小組醫師協會（IPPA）建立合作伙伴關係，以支持和教育全球各地的專科醫生了解最新的結核病（TB）篩查要求。將特別關注新的干擾素伽瑪釋放試驗（IGRA）要求以及患者和醫療保健提供者的相關益處。
This collaboration follows the U.S. Centers for Disease Control and Prevention (CDC) updating its guidelines for new TB screening requirements for immigrants to the United States. Together, QIAGEN and IPPA are committed to promoting the use of IGRA testing, such as QIAGEN...
此次合作是在美國疾病控制與預防中心（CDC）更新其針對移民到美國的新結核病篩查要求的指...
登入免費觀看全文
登入/註冊